Table 3.
QIs as a ratio (nominator: denominator) | Acceptable range (%) | Median, range 1–9 |
---|---|---|
Patients with acute pharyngotonsillitis | ||
Number of patients treated with penicillin V: number of patients treated with antibiotics | 90–100 | 9* |
Number of patients with known penicillin allergy treated with macrolides: number of patients treated with macrolides | 90–100 | 9* |
Number of patients without known penicillin allergy treated with macrolides: number of patients treated with macrolides | 0–10 | 9* |
Patients with acute otitis media | ||
Number of patients treated with penicillin V: number of patients treated with antibiotics | 90–100 | 9* |
Number of patients treated with amoxicillin ± clavulanic acid: number of patients treated with antibiotics | 0–20 | 9* |
Number of patients with known penicillin allergy treated with macrolides: number of patients treated with macrolides | 90–100 | 9* |
Number of patients without known penicillin allergy treated with macrolides: number of patients treated with macrolides | 0–10 | 9* |
Patients with acute rhinosinusitis | ||
Number of patients treated with penicillin V: number of patients treated with antibiotics | 90–100 | 9* |
Number of patients treated with amoxicillin ± clavulanic acid: number of patients treated with antibiotics | 0–20 | 9 |
Number of patients with known penicillin allergy treated with macrolides: number of patients treated with macrolides | 90–100 | 9* |
Number of patients without known penicillin allergy treated with macrolides: number of patients treated with macrolides | 0–10 | 9* |
Patients with acute bronchitis | ||
Number of patients treated with penicillin V: number of patients treated with antibiotics | 90–100 | 9* |
Number of patients treated with amoxicillin ± clavulanic acid: number of patients treated with antibiotics | 0–10 | 9* |
Number of patients with known penicillin allergy treated with macrolides: number of patients treated with macrolides | 90–100 | 9* |
Number of patients without known penicillin allergy treated with macrolides: number of patients treated with macrolides | 0–10 | 9* |
Patients with pneumonia | ||
Number of patients treated with penicillin V: number of patients treated with antibiotics | 80–100 | 9* |
Number of patients with known penicillin allergy treated with macrolides: number of patients treated with macrolides | 90–100 | 9* |
Number of patients without known penicillin allergy treated with macrolides: number of patients treated with macrolides | 0–10a | 9* |
Patients with acute exacerbation of COPD | ||
Number of patients treated with amoxicillin ± clavulanic acid: number of patients treated with antibiotics | 80–100 | 8 |
Number of patients without known penicillin allergy treated with quinolones: number of patients treated with quinolones | 0–10 | 9* |
Patients with acute RTI | ||
Number of patients without known penicillin allergy treated with macrolides: number of patients treated with macrolides | 0–10 | 9* |
Consensus of appropriateness.
This standard cannot be used during a mycoplasma epidemic.